• Explore /
  • Poster
  • / Comparing clinical outcomes between patients with urothelial carcinoma who treated neoadjuvant chemotherapy by gemcitabine-cisplatin and dose-dense MVAC.

Comparing clinical outcomes between patients with urothelial carcinoma who treated neoadjuvant chemotherapy by gemcitabine-cisplatin and dose-dense MVAC.

Abstract Poster

Authors

null

Yongjune Lee

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Yongjune Lee , Young Seok Kim , Bumsik Hong , Yong Mee Cho , Jae-Lyun Lee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 376)

DOI

10.1200/JCO.2019.37.7_suppl.376

Abstract #

376

Poster Bd #

F11

Abstract Disclosures

Similar Posters

First Author: Srikala S. Sridhar

First Author: Ali Raza Khaki

First Author: Benjamin Miron

First Author: Lauren Christine Harshman